Valeant Pharmaceuticals (VRX) Stock: Skyrockets On Strong Earnings

Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) is off to an incredibly strong start to the day in the pre-market hours today, and for good reason. The company reported earnings for the first quarter. While revenue missed the mark, earnings soared, and guidance proved to be positive. As a result, investor excitement ensued, and the stock … Read more

Valeant Pharmaceuticals (VRX) Stock: Falling On Competition

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals hasn’t been having the best of times in the market for a long time now. However, today, it seems as though losses have amplified. The stock started the day off in the red, and throughout the session thus far, we’ve seen a continuation of losses. Below, we’ll … Read more

Valeant Pharmaceuticals (VRX) Stock: Can It Get Any Worse?

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals was already off to an incredibly rough start in the market today. After news that the Salix asset sale was falling apart hit, the stock quickly found big losses and continued to slide throughout the day. Now, yet another story is cresting, and the stock is breaking … Read more

Valeant Pharmaceuticals (VRX) Stock: Breaking Down As Asset Sale Falls Apart

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals was off to a relatively normal day in the market. While the stock was in the red, it wasn’t down by too much. That is, until minutes ago when the stock started to spike downward. Below, we’ll talk about what we’re seeing from the stock, why, and … Read more